Tranexamic Acid Tablets A202093 1
Tranexamic Acid Tablet, Film Coated
Product Images NDC 0591-3720
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid (NDC 0591-3720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tranexamic Acid Tablets A202093 2
This appears to be a table showing the Mean Menstrual Blood Loss (in milliliters) for different treatment periods (Baseline, Cycle 1, Cycle 2, etc.) and different treatments (Tranexamic Acid Tablets 3300mg/day, Placebo, Tranexamic Acid Tablets 3900mg/day, Placebo) for a study related to menstrual bleeding.*
Tranexamic Acid Tablets A202093 3
This is a description of medication packaging - Tranexamic Acid Tablets containing 650mg each. It provides storage instructions and a cautionary note in regards to temperature. The manufacturer's name, Teva, is mentioned along with a product code and a unique identification number.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
